EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluation of serum Prostate Specific Antigen in Elderly Men with Type 2 Diabetes

Manoj Acharya, Binod Kumar Lal Das, Madhab Lamsal, Bishal Khattri, Rikesh Jung Karkee, Sneha Sinha, Nirmal Baral

Journal of Rapti Academy of Health Sciences · 07.04.2026 · 2 (2) · 40-44

DOI: 10.70027/jrahs97 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Rapti Academy of Health Sciences, online erschienen am 07.04.2026. Verfasst von Manoj Acharya und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prostate-specific antigen is a vital marker while evaluating prostate health, mainly in diagnosing prostate cancer. However, the exactness of assessing the risk of prostate cancer may be reduced by changes in men with type 2 diabetes. There is evidence that males with type 2 diabetes have a decreased incidence of prostate cancer, despite the fact that the disease is linked to an increased risk of cancer, including pancreatic, liver and breast. The main objective of our study is the comparison of serum PSA levels in elderly males with Type 2 diabetes to those participants who do not have diabetes.

Methods

A comparative, cross-sectional study with participation of 100 males aged 40 and older; fifty of them had diabetes and the other fifty did not. Immunoturbidimetry and chemiluminescence immunoassay (CLIA) were used to assess the levels of HbA1c and serum PSA, respectively. The statistical analysis comprised the chi-square test, Mann-Whitney U test and Spearman correlation with a significance level of p < 0.05.

Results

Participants with diabetes had median PSA levels that were significantly lower (0.92 ng/mL) than those without the disease (1.1 ng/mL; p = 0.01). Correlation analysis showed that PSA levels of subjects was positively correlated with age (r = 0.31, p = 0.002), while PSA was negatively correlated with HbA1c (r = -0.27, p = 0.007).

Conclusions

This study shows that men with Type 2 diabetes have lower serum PSA levels than men without diabetes. The findings suggest to account diabetes status while interpreting PSA results in prostate cancer screening.

Zitieren

APA

Acharya, M., Das, B. K. L., Lamsal, M., Khattri, B., Karkee, R. J., Sinha, S., & Baral, N. (2026). Evaluation of serum Prostate Specific Antigen in Elderly Men with Type 2 Diabetes. Journal of Rapti Academy of Health Sciences, 2(2), 40-44. https://doi.org/10.70027/jrahs97

Vancouver

Acharya M, Das BKL, Lamsal M, Khattri B, Karkee RJ, Sinha S, et al. Evaluation of serum Prostate Specific Antigen in Elderly Men with Type 2 Diabetes. Journal of Rapti Academy of Health Sciences. 2026;2(2):40-44. doi:10.70027/jrahs97

BibTeX
@article{Acharya2026,
  author = {Acharya, Manoj and Das, Binod Kumar Lal and Lamsal, Madhab and Khattri, Bishal and Karkee, Rikesh Jung and Sinha, Sneha and Baral, Nirmal},
  title = {Evaluation of serum Prostate Specific Antigen in Elderly Men with Type 2 Diabetes},
  journal = {Journal of Rapti Academy of Health Sciences},
  year = {2026},
  volume = {2},
  number = {2},
  pages = {40--44},
  doi = {10.70027/jrahs97}
}
Kostenlos starten →